270 related articles for article (PubMed ID: 1608956)
1. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956
[TBL] [Abstract][Full Text] [Related]
2. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
[TBL] [Abstract][Full Text] [Related]
3. N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.
Tekirian TL; Saido TC; Markesbery WR; Russell MJ; Wekstein DR; Patel E; Geddes JW
J Neuropathol Exp Neurol; 1998 Jan; 57(1):76-94. PubMed ID: 9600199
[TBL] [Abstract][Full Text] [Related]
4. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
5. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics.
Esler WP; Stimson ER; Ghilardi JR; Vinters HV; Lee JP; Mantyh PW; Maggio JE
Biochemistry; 1996 Jan; 35(3):749-57. PubMed ID: 8547255
[TBL] [Abstract][Full Text] [Related]
6. [Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].
Duyckaerts C; Delaère P; He Y; Seilhean D; Hauw JJ
Presse Med; 1994 May; 23(18):848-54. PubMed ID: 7937606
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of a monoclonal antibody 369.2B specific for the carboxyl-terminus of the beta A4 peptide.
König G; Graham P; Bushnell A; Webster S; Wunderlich D; Perlmutter LS
Ann N Y Acad Sci; 1996 Jan; 777():344-55. PubMed ID: 8624111
[TBL] [Abstract][Full Text] [Related]
8. Brain parenchymal and microvascular amyloid in Alzheimer's disease.
Vinters HV; Wang ZZ; Secor DL
Brain Pathol; 1996 Apr; 6(2):179-95. PubMed ID: 8737932
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease.
Armstrong RA
Dementia; 1995; 6(3):121-5. PubMed ID: 7620523
[TBL] [Abstract][Full Text] [Related]
10. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
11. Colocalization of amino terminal and A4 (beta-amyloid) antigens in Alzheimer plaques: evidence for coordinated processing of the amyloid precursor protein.
Tate-Ostroff B; Majocha RE; Walcott EC; Ventosa-Michelman M; Marotta CA
J Geriatr Psychiatry Neurol; 1990; 3(3):139-45. PubMed ID: 2126439
[TBL] [Abstract][Full Text] [Related]
12. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
13. Quantitative differences in the deposition of beta A4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease.
Gentleman SM; Allsop D; Bruton CJ; Jagoe R; Polak JM; Roberts GW
Neurosci Lett; 1992 Feb; 136(1):27-30. PubMed ID: 1635663
[TBL] [Abstract][Full Text] [Related]
14. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the Alzheimer's amyloid beta-peptide.
Soto C; Brañes MC; Alvarez J; Inestrosa NC
J Neurochem; 1994 Oct; 63(4):1191-8. PubMed ID: 7931272
[TBL] [Abstract][Full Text] [Related]
16. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
17. The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.
Armstrong RA; Myers D; Smith CU
Acta Neuropathol; 1993; 86(1):36-41. PubMed ID: 8372640
[TBL] [Abstract][Full Text] [Related]
18. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.
Baker HF; Ridley RM; Duchen LW; Crow TJ; Bruton CJ
Mol Neurobiol; 1994 Feb; 8(1):25-39. PubMed ID: 8086126
[TBL] [Abstract][Full Text] [Related]
19. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
20. Interaction of rat brain phosphofructokinase with Alzheimer's beta A4-amyloid.
Bigl M; Eschrich K
Neurochem Int; 1995 Jan; 26(1):69-75. PubMed ID: 7787764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
